NOT KNOWN FACTUAL STATEMENTS ABOUT MBL77

Whilst lower-count MBL not often progresses to CLL, significant-depend MBL progresses to CLL demanding therapy in a fee of 1% to 2% per annum. Substantial-count MBL is distinguished from Rai 0 CLL determined by whether the B-cell rely is higher than or under 5 × 109/L. Despite the fact that persons with both high-count MBL and CLL Rai stage 0 are